MA30015B1 - Stabilisation de testosterone au sein de dispositifs transdermiques - Google Patents
Stabilisation de testosterone au sein de dispositifs transdermiquesInfo
- Publication number
- MA30015B1 MA30015B1 MA30982A MA30982A MA30015B1 MA 30015 B1 MA30015 B1 MA 30015B1 MA 30982 A MA30982 A MA 30982A MA 30982 A MA30982 A MA 30982A MA 30015 B1 MA30015 B1 MA 30015B1
- Authority
- MA
- Morocco
- Prior art keywords
- testosterone
- stabilization
- transdermal devices
- desiccant
- chemical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
STABILISATION DE TESTOSTERONE AU SEIN DE DISPOSITIFS TRANSDERMIQUES Résumé: La présente invention concerne la stabilisation chimique de la testostérone contenue dans des dispositifs transdermiques autoadhésifs via l'association d'un agent dessicant avec ledit dispositif au sein d'un emballage étanche. L'utilisation d'un agent dessicant permet de limiter la dégradation chimique de la testostérone en androstènedione et autres impuretés et assure ainsi une conservation dudit dispositif sur des durées allant jusqu'à trente-six mois.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0513435A FR2895679B1 (fr) | 2005-12-29 | 2005-12-29 | Stabilisation de testosterone au sein de dispositifs transdermiques |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30015B1 true MA30015B1 (fr) | 2008-12-01 |
Family
ID=37075280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30982A MA30015B1 (fr) | 2005-12-29 | 2008-06-02 | Stabilisation de testosterone au sein de dispositifs transdermiques |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080317859A1 (fr) |
EP (1) | EP1965749A1 (fr) |
JP (1) | JP2009522243A (fr) |
KR (1) | KR20080081166A (fr) |
CN (1) | CN101351180A (fr) |
AU (1) | AU2006329751A1 (fr) |
BR (1) | BRPI0620839A2 (fr) |
CA (1) | CA2635422A1 (fr) |
FR (1) | FR2895679B1 (fr) |
IL (1) | IL192406A0 (fr) |
MA (1) | MA30015B1 (fr) |
NO (1) | NO20083306L (fr) |
NZ (1) | NZ568658A (fr) |
RU (1) | RU2419436C2 (fr) |
TN (1) | TNSN08286A1 (fr) |
UA (1) | UA97354C2 (fr) |
WO (1) | WO2007074239A1 (fr) |
ZA (1) | ZA200805157B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2018098501A1 (fr) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Traitement oral à base d'undécanoate de testostérone |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE19517145C2 (de) * | 1995-05-10 | 2000-02-24 | Hexal Pharmaforschung Gmbh | Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron |
US5698217A (en) * | 1995-05-31 | 1997-12-16 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device containing a desiccant |
CA2273921C (fr) * | 1996-12-03 | 2005-10-25 | Minnesota Mining And Manufacturing Company | Distributeurs de timbres transdermiques/transmuqueux |
GB9720470D0 (en) * | 1997-09-25 | 1997-11-26 | Ethical Pharmaceuticals South | Inhibition of crystallization in transdermal devices |
DE19913761B4 (de) * | 1999-03-26 | 2005-02-10 | Lts Lohmann Therapie-Systeme Ag | Trocknungsvorrichtung und Verfahren zu ihrer Herstellung sowie ihre Verwendung |
FR2793689B1 (fr) * | 1999-05-19 | 2001-08-24 | Pf Medicament | Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives |
DE19925613A1 (de) * | 1999-06-04 | 2000-12-07 | Lohmann Therapie Syst Lts | Verbundlaminat und Verfahren zu seiner Herstellung |
US6905016B2 (en) * | 2000-03-14 | 2005-06-14 | Noven Pharmaceuticals, Inc. | Packaging system for transdermal drug delivery systems |
-
2005
- 2005-12-29 FR FR0513435A patent/FR2895679B1/fr not_active Expired - Fee Related
-
2006
- 2006-12-26 BR BRPI0620839-8A patent/BRPI0620839A2/pt not_active IP Right Cessation
- 2006-12-26 JP JP2008548013A patent/JP2009522243A/ja active Pending
- 2006-12-26 WO PCT/FR2006/002873 patent/WO2007074239A1/fr active Application Filing
- 2006-12-26 RU RU2008131064/15A patent/RU2419436C2/ru not_active IP Right Cessation
- 2006-12-26 NZ NZ568658A patent/NZ568658A/en not_active IP Right Cessation
- 2006-12-26 EP EP06847141A patent/EP1965749A1/fr not_active Withdrawn
- 2006-12-26 US US12/086,964 patent/US20080317859A1/en not_active Abandoned
- 2006-12-26 CN CNA2006800495563A patent/CN101351180A/zh active Pending
- 2006-12-26 AU AU2006329751A patent/AU2006329751A1/en not_active Abandoned
- 2006-12-26 UA UAA200809847A patent/UA97354C2/ru unknown
- 2006-12-26 CA CA002635422A patent/CA2635422A1/fr not_active Abandoned
- 2006-12-26 KR KR1020087016196A patent/KR20080081166A/ko not_active Application Discontinuation
-
2008
- 2008-06-02 MA MA30982A patent/MA30015B1/fr unknown
- 2008-06-12 ZA ZA200805157A patent/ZA200805157B/xx unknown
- 2008-06-23 IL IL192406A patent/IL192406A0/en unknown
- 2008-06-27 TN TNP2008000286A patent/TNSN08286A1/fr unknown
- 2008-07-25 NO NO20083306A patent/NO20083306L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1965749A1 (fr) | 2008-09-10 |
RU2419436C2 (ru) | 2011-05-27 |
KR20080081166A (ko) | 2008-09-08 |
AU2006329751A1 (en) | 2007-07-05 |
CA2635422A1 (fr) | 2007-07-05 |
FR2895679B1 (fr) | 2012-06-08 |
ZA200805157B (en) | 2009-06-24 |
NO20083306L (no) | 2008-09-16 |
FR2895679A1 (fr) | 2007-07-06 |
US20080317859A1 (en) | 2008-12-25 |
UA97354C2 (ru) | 2012-02-10 |
IL192406A0 (en) | 2008-12-29 |
CN101351180A (zh) | 2009-01-21 |
JP2009522243A (ja) | 2009-06-11 |
WO2007074239A1 (fr) | 2007-07-05 |
RU2008131064A (ru) | 2010-02-10 |
NZ568658A (en) | 2011-10-28 |
TNSN08286A1 (fr) | 2009-10-30 |
BRPI0620839A2 (pt) | 2011-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30015B1 (fr) | Stabilisation de testosterone au sein de dispositifs transdermiques | |
DK1284771T3 (da) | Aerosolbeholder til formuleringer af salmeterol-xinafoat | |
BR0004148A (pt) | Dispositivo de acondicionamento e de aplicação | |
RS51194B (sr) | Formulacija tienopiridina kao inhibitora agregacije plateleta | |
ATE397469T1 (de) | Packung mit medikament und spendevorrichtung dafür | |
WO2006125577A3 (fr) | Nebuliseur | |
FR2909002B1 (fr) | Dispositif melangeur de gaz pour appareils d'assistance respiratoire. | |
WO2007076350A3 (fr) | Emballage d’inhibiteur de corrosion volatil | |
ATE428387T1 (de) | Urinbeutel | |
WO2008094618A3 (fr) | Lavement amélioré à effet irritant réduit destiné au traitement d'une affection intestinale inflammatoire (ibd) | |
TW200509989A (en) | Stabilized pharmaceutical product | |
EP2260871A3 (fr) | Complexes d'inclusions comprenant du piroxicam, une cyclodextrine et l'arginine | |
WO2007076239A3 (fr) | Sac rempli de liquide et ensemble surenveloppe | |
SE0400864D0 (sv) | Vridlåsanordning | |
ATE315361T1 (de) | Zahnärztlicher matrizenspanner | |
DE602004028585D1 (de) | Verpackung für Arzneimittel | |
ATE324869T1 (de) | Blisterverpackung und feste dosierungsform enthaltend desmopressin | |
TW200628894A (en) | Liquid crystal orientation agent and liquid crystal display element | |
FR2887579B1 (fr) | Dispositif de protection anti chute pour porte de manutention | |
FR2856150B1 (fr) | Dispositif pour evaluer la concentration d'au moins une espece chimique dans une phase gazeuse | |
BR8303018U (pt) | Disposição construtiva introduzida em tampa com lacre e sistema | |
FR2817715A1 (fr) | Boitier de maquillage muni de moyens garantissant l' etancheite et la mise sous vide du contenu | |
TH81027A (th) | ขวดแบบที่มีการป้องกันและวิธีการผลิตเพื่อการนั้น | |
YOSHIMURA | The Background of Standardization for Mechanization of Vegetables | |
TH81027B (th) | ขวดแบบที่มีการป้องกันและวิธีการผลิตเพื่อการนั้น |